BRAFm+ metastatic melanoma
What makes it different makes it vulnerable
Information and advances in our understanding of melanoma continue to evolve. Approximately half of all cases of melanoma harbour a mutation in BRAF, making it the most common genetic subtype of cutaneous melanoma.1,2
Here you’ll find information about BRAF mutation and its role in melanoma, the rationale for BRAF-mutation testing and treatment with BRAF inhibitors, the procedures for BRAF-mutation testing, and the testing methods that are available.